WASHINGTON (AFP) -- The U.S. Food and Drug Administration (FDA) has approved a drug which has been found to allow with multiple sclerosis (MS) to walk faster, the drug watchdog said.
 All Content by Mehr News Agency is licensed under a Creative Commons Attribution 4.0 International License.